BioVendor – Laboratory Medicine Ltd.

BioVendor, Laboratory Medicine Ltd. develops, manufactures and distributes research and diagnostic products for biomedical laboratories and the international scientific community. Its portfolio brings together immunoassays, recombinant proteins, monoclonal and polyclonal antibodies, and products for endotoxin detection and removal. The company also develops in vitro diagnostic technologies for laboratory automation, with chemiluminescence immunodiagnostic tests designed for the automated KleeYa® platform. Its work extends to biomarkers and tests relevant to inflammation, sepsis, cardiovascular disease, diabetes and hemostatic disorders, alongside tools for tissue engineering and molecular analysis.

Research and development form a central part of the business, including publicly funded collaborations with scientific and research partners and investment in facilities for diagnostic test development, testing and specialized analytical services. BioVendor combines product development with production, distribution, laboratory instrument service and technical support. ISO 9001 and ISO 13485 certification cover the development, production and distribution of in vitro diagnostics and laboratory chemicals, as well as the distribution and service of laboratory instruments. This integrated model positions the company across research reagents, clinical laboratory diagnostics and automated analytical workflows.